Trial Profile

International Multicenter Single Blind Randomized Clinical Study to Compare Efficacy and Safety of Remimazolam and Propofol in Patients Undergoing Elective Surgical Procedures Under General Anesthesia

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Aug 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fentanyl (Primary) ; Remimazolam (Primary) ; Rocuronium bromide (Primary) ; Propofol
Indications General anaesthesia
Focus Registrational; Therapeutic Use
Sponsors R-Pharm

12 Aug 2020 According to the PAION media release, R-Pharm is currently preparing first market approval dossiers for the licensed territories.
06 Nov 2018 According to a R-Pharm media release, the company expects to submit regulatory application with the Ministry of Healthcare of the Russian Federation in Q1 2019.
21 Sep 2018 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com